Innovative Technologies in Early Drug Discovery
In this webinar, WuXi AppTec scientists discuss the latest innovative technologies and products in early-stage drug discovery. Viewers will gain...
Continue Reading
In this webinar, WuXi AppTec scientists discuss the latest innovative technologies and products in early-stage drug discovery. Viewers will gain...
Continue Reading
Currently, there is a lack of efficient experimental strategies to collect high-quality proteome-level data for protein-ligand interactions (PLIs). At DEL...
Continue Reading
DNA-encoded library (DEL) technology has been recognized as a major screening method with unique advantages for offering vast chemical diversity...
Continue Reading
With advancements in drug design, there is resurging interest in drugs that form covalent bonds with their targets. Covalent drugs...
Continue Reading
RNA-targeted therapeutics are highly intriguing due to their unique physiological properties and novel modes of action in drug R&D. Developing...
Continue Reading
Bromodomain and extra-terminal domain (BET) family proteins are key regulators of gene transcription and have been implicated in a wide...
Continue Reading
Tuberculosis is the leading cause of death from an infectious disease and is caused by Mycobacterium tuberculosis (MTB). Inosine-5′-monophosphate dehydrogenase...
Continue Reading
In the last decade, targeted protein degradation (TPD) technology has become one of the most promising methods to remove specific...
Continue Reading
WuXi AppTec offers a comprehensive platform of in silico drug discovery services to accelerate the process of hit finding and...
Continue Reading